SPY424.48-0.78 -0.18%
DIA343.41-0.89 -0.26%
IXIC14,072.86-101.29 -0.71%

--HC Wainwright Adjusts BioXcel Therapeutics' Price Target to $170 From $175, Keeps Buy Rating

05/11/2021 06:00

09:47 AM EDT, 05/11/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 30.03, Change: -0.37, Percent Change: -1.22